Expressing concerns over unregulated medicinal products containing stem cells. The Agency highlights that access to stem-cell medicinal products should only be under certain controlled conditions.
A social network of Rare Disease Communities led by NORD and EURORDIS in partnership with leading disease-specific patient groups. List of Rare Disease Communities: